Undervalued Growth and Dividend Growth in Health Technology: Part 11

Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.  With only a few minor exceptions, this is true for most companies, especially the pharmaceutical companies, operating in this sector. On the other hand, there are several examples Read more about Undervalued Growth and Dividend Growth in Health Technology: Part 11[…]

Building a Dividend Growth Portfolio from Scratch: 15 A Rated or Better Fairly Valued Opportunities

Introduction We remain in one of the longest bull markets in history.  Generally, with bull markets stocks tend to become highly valued.  Additionally, we also continue to find ourselves in a low interest rate environment based on historical standards.  However, after bottoming out in January 2017, interest rates have steadily increased.  Although interest rates remain Read more about Building a Dividend Growth Portfolio from Scratch: 15 A Rated or Better Fairly Valued Opportunities[…]